In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental members will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Phase C, participants https://brd4-targeted-therapy-abb24578.blog-mall.com/32500791/rumored-buzz-on-abbv-744-as-a-potential-therapeutic-option-for-aggressive-cancers